Related Experiment Video
Updated: Jun 15, 2026
06:10
Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock
Published on: June 12, 2021
3.2K
Cardiogenic Shock Teams: Past, Present, and Future Directions
Vanessa Blumer1, Thomas C Hanff2, Ann Gage3
1Inova Schar Heart and Vascular, Falls Church, VA (V.B.).
Circulation. Heart Failure
|March 28, 2025
Summary
Structured cardiogenic shock (CS) teams improve survival rates and reduce complications. Standardizing protocols, prompt recognition, and early interventions are crucial for better patient outcomes in CS management.
Area of Science:
- Cardiovascular Medicine
- Critical Care Medicine
Background:
- Cardiogenic shock (CS) presents significant morbidity and mortality challenges.
- Historically, patient outcomes in CS are highly variable, depending on intervention timing and center expertise.
- Emerging evidence supports structured, team-based approaches for improving CS survival rates.
Purpose of the Study:
- To review the evolution, current implementation, and future directions of cardiogenic shock (CS) teams.
- To emphasize the critical role of CS teams in enhancing patient outcomes.
- To advocate for standardized protocols and integrated management strategies.
Main Methods:
- Review of existing literature on cardiogenic shock team models.
- Analysis of challenges in team composition and resource distribution.
- Discussion of standardized protocols, hemodynamic monitoring, and mechanical circulatory support.
Main Results:
- Structured team-based approaches significantly improve survival rates and diminish CS complications.
- Standardized protocols are essential for uniform care delivery across institutions.
- Early recognition and management, including invasive monitoring and mechanical support, are vital.
Conclusions:
- CS teams are crucial for improving patient outcomes and survival rates.
- Standardization, innovation, and data sharing through national registries are imperative.
- Extending CS team models into regional networks can broaden their impact via education and telemedicine.
Related Concept Videos
01:24Blood Pressure Imbalances and Circulatory Shock
Disorders affecting blood volume, vascular tone, or vascular function can disrupt vascular homeostasis, including conditions like hypertension, hemorrhage, and shock.
Blood Pressure: Hypertension and Hypotension
Normal blood pressure is 120/80 mm Hg. Elevated blood pressure is 120-129/under 80 mm Hg. Hypertension, warranting treatment at 130/80 mm Hg, is often asymptomatic and can lead to severe cardiovascular events, aneurysms, peripheral arterial disease, chronic renal disease, or cardiac...
Blood Pressure: Hypertension and Hypotension
Normal blood pressure is 120/80 mm Hg. Elevated blood pressure is 120-129/under 80 mm Hg. Hypertension, warranting treatment at 130/80 mm Hg, is often asymptomatic and can lead to severe cardiovascular events, aneurysms, peripheral arterial disease, chronic renal disease, or cardiac...
01:28Acute Coronary Syndrome IV: Interprofessional Care
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
01:23Cardiopulmonary Resuscitation III: AED Use
Introduction to AEDAn Automated External Defibrillator (AED) is a portable medical device that analyzes the heart's rhythm and, if necessary, delivers an electrical shock to help the heart re-establish an effective rhythm during sudden cardiac arrest (SCA). SCA occurs when the heart suddenly and unexpectedly stops beating, leading to a loss of blood flow to the brain and other vital organs. In such emergencies, time is of the essence, and using an AED, combined with Cardiopulmonary...
01:25Cardiopulmonary Resuscitation IV: Pharmacological Management
Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
01:30Cardiomyopathy II: Dilated Cardiomyopathy
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
01:29Cardiomyopathy V: Interprofessional Care
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...